Benign prostatic hyperplasia is a significant risk factor for bladder cancer in diabetic patients: a population-based cohort study using the National Health Insurance in Taiwan-Reference-Cited by-同舟云学术

Benign prostatic hyperplasia is a significant risk factor for bladder cancer in diabetic patients: a population-based cohort study using the National Health Insurance in Taiwan

Published:2013-01-04 Issue:1 Volume:13 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Tseng Chin-Hsiao

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/1471-2407-13-7.pdf

Reference42 articles.

1. Wei JT, Calhoun E, Jacobsen SJ: Urologic diseases in America project: benign prostatic hyperplasia. J Urol. 2008, 179 (5 Suppl): S75-S80.

2. Zhang Y, Zhu C, Curado MP, Zheng T, Boyle P: Changing patterns of bladder cancer in the USA: evidence of heterogeneous disease. BJU Int. 2012, 109: 52-56.

3. Parsons JK: Benign prostatic hyperplasia and male lower urinary tract symptoms: epidemiology and risk factors. Curr Bladder Dysfunct Rep. 2010, 5: 212-218. 10.1007/s11884-010-0067-2.

4. Matsumoto S, Shimizu N, Hanai T, Uemura H, Levin R: Bladder outlet obstruction accelerates bladder carcinogenesis. BJU Int. 2009, 103: 1436-1439. 10.1111/j.1464-410X.2008.08261.x.

5. Mommsen S, Sell A: Prostatic hypertrophy and venereal disease as possible risk factors in the development of bladder cancer. Urol Res. 1983, 11: 49-52.

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From TURP to enucleation: navigating the complex relationship between BPH treatments and bladder cancer;World Journal of Urology;2024-03-29

2. Systematic Evaluation of Imaging Features of Early Bladder Cancer Using Computed Tomography Performed before Pathologic Diagnosis;Tomography;2023-09-11

3. Genetically supported causality between benign prostate hyperplasia and urinary bladder neoplasms: A mendelian randomization study;Frontiers in Genetics;2022-11-17

4. Pioglitazone, Bladder Cancer, and the Presumption of Innocence;Current Drug Safety;2022-11

5. The “Diabetes Comorbidome”: A Different Way for Health Professionals to Approach the Comorbidity Burden of Diabetes;Healthcare;2022-08-03